Evidence map›Paper›PMID 35237386›Full record

ArticleOxidative medicine and cellular longevity2022

D-dimer, CRP, PCT, and IL-6 Levels at Admission to ICU Can Predict In-Hospital Mortality in Patients with COVID-19 Pneumonia.

Marija Milenkovic, Adi Hadzibegovic, Mirjana Kovac, Bojan Jovanovic, Jovana Stanisavljevic, Marina Djikic, Djuro Sijan, Nebojsa Ladjevic, Ivan Palibrk, Marija Djukanovic and 15 more

Abstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Serum inflammatory markers in children withWorld journal of clinical cases · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Lipoxin AFrontiers in immunology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Marija MilenkovicUniversity Clinical Centre of Serbia, Belgrade, Serbia.ORCID https://orcid.org/0000-0002-3275-2288
Adi HadzibegovicUniversity Clinical Centre of Serbia, Belgrade, Serbia.ORCID https://orcid.org/0000-0003-4956-3093
Mirjana KovacBlood Transfusion Institute of Serbia, Belgrade, Serbia.
Bojan JovanovicUniversity Clinical Centre of Serbia, Belgrade, Serbia.ORCID https://orcid.org/0000-0002-8699-6456
Jovana StanisavljevicUniversity Clinical Centre of Serbia, Belgrade, Serbia.
Marina DjikicUniversity Clinical Centre of Serbia, Belgrade, Serbia.
Djuro SijanFaculty of Medicine, University of Belgrade, Belgrade, Serbia.
Nebojsa LadjevicUniversity Clinical Centre of Serbia, Belgrade, Serbia.
Ivan PalibrkUniversity Clinical Centre of Serbia, Belgrade, Serbia.
Marija DjukanovicUniversity Clinical Centre of Serbia, Belgrade, Serbia.
Jelena VelickovicUniversity Clinical Centre of Serbia, Belgrade, Serbia.
Sanja RatkovicUniversity Clinical Centre of Serbia, Belgrade, Serbia.
Milica BrajkovicUniversity Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia.
Viseslav PopadicUniversity Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia.ORCID https://orcid.org/0000-0002-0992-7481
Slobodan KlasnjaUniversity Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia.
Borislav ToskovicFaculty of Medicine, University of Belgrade, Belgrade, Serbia.
Darko ZdravkovicFaculty of Medicine, University of Belgrade, Belgrade, Serbia.
Bogdan CrnokrakFaculty of Medicine, University of Belgrade, Belgrade, Serbia.
Olivera MarkovicFaculty of Medicine, University of Belgrade, Belgrade, Serbia.
Jelica Bjekic-MacutFaculty of Medicine, University of Belgrade, Belgrade, Serbia.
Aleksandra AleksicUniversity Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia.
Simona PetricevicUniversity Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia.
Lidija MemonUniversity Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia.
Ana MilojevicUniversity Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia.
Marija ZdravkovicFaculty of Medicine, University of Belgrade, Belgrade, Serbia.ORCID https://orcid.org/0000-0003-4059-0263

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHealth care workers have had a challenging task since the COVID-19 outbreak. Prompt and effective predictors of clinical outcomes are crucial to recognize potentially critically ill patients and improve the management of COVID-19 patients. The aim of this study was to identify potential predictors of clinical outcomes in critically ill COVID-19 patients.

methodsThe study was designed as a retrospective cohort study, which included 318 patients treated from June 2020 to January 2021 in the Intensive Care Unit (ICU) of the Clinical Hospital Center "Bezanijska Kosa" in Belgrade, Serbia. The verified diagnosis of COVID-19 disease, patients over 18 years of age, and the hospitalization in ICU were the criteria for inclusion in the study. The optimal cutoff value of D-dimer, CRP, IL-6, and PCT for predicting hospital mortality was determined using the ROC curve, while the Kaplan-Meier method and log-rank test were used to assess survival.

resultsThe study included 318 patients: 219 (68.9%) were male and 99 (31.1%) female. The median age of patients was 69 (60-77) years. During the treatment, 195 (61.3%) patients died, thereof 130 male (66.7%) and 65 female (33.3%). 123 (38.7%) patients were discharged from hospital treatment. The cutoff value of IL-6 for in-hospital death prediction was 74.98 pg/mL (Sn 69.7%, Sp 62.7%); cutoff value of CRP was 81 mg/L (Sn 60.7%, Sp 60%); cutoff value of procalcitonin was 0.56 ng/mL (Sn 81.1%, Sp 76%); and cutoff value of D-dimer was 760 ng/mL FEU (Sn 63.4%, Sp 57.1%). IL-6 ≥ 74.98 pg/mL, CRP ≥ 81 mg/L, PCT ≥ 0.56 ng/mL, and D-dimer ≥ 760 ng/mL were statistically significant predictors of in-hospital mortality.

conclusionIL-6 ≥ 74.98 pg/mL, CRP values ≥ 81 mg/L, procalcitonin ≥ 0.56 ng/mL, and D-dimer ≥ 760 ng/mL could effectively predict in-hospital mortality in COVID-19 patients.

Indexed as

COVID-19Hospital MortalityIntensive Care UnitsPatient AdmissionAgedC-Reactive ProteinFemaleFibrin Fibrinogen Degradation ProductsHumansInterleukin-6MaleMiddle AgedRetrospective StudiesSARS-CoV-2C-Reactive ProteinFibrin Fibrinogen Degradation Productsfibrin fragment DIL6 protein, humanInterleukin-6

Identifiers

PMID35237386
PMCPMC8884120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.